Dream comes true for young gymnast bi13751143 Danica Murray's dream to attend a gymnastics camp came true earlier month at the International Gymnastics Camp Stroudsburg, Va

Research and Markets: Cystic Fibrosis - A Comprehensive Global Strategic Busi bi13751143 DUBLIN----Research and Markets has announced the addition of the "Cystic Fibrosis - Global Strategic Business Report" report to offering

Dream comes true for young gymnast bi13751143 Danica Murray's dream to attend a gymnastics camp came true earlier month at the International Gymnastics Camp Stroudsburg, Va

St Vincent's CF unit stalls over builder bi13751143 PLANS FOR a specialist cystic fibrosis unit face the possibility of further delays after the hospital involved moved yesterday to recruit a new builder for the 20 million-plus project

Lilly To Acquire Alnara Pharmaceuticals bi13751143 Eli Lilly and Company (NYSE: LLY) and Alnara Pharmaceuticals, Inc. today announced they have signed a definitive merger agreement whereby Lilly acquire Alnara, a privately held biotechnology company developing protein therapeutics for the of metabolic diseases

First of Its Kind Salt Room Opens Florida bi13751143 Folks relaxing salt room to relieve allergies, asthma, and other respiratory problems

Reportlinker Adds Innovations Combating Infectious Diseases: Opportunities bi13751143 Reportlinker.com announces that a new market research report available catalogue:..

Reportlinker Adds The Future of Molecular Diagnostics: Innovative Technologie bi13751143 NEW YORK , July 6 /PRNewswire/ -- Reportlinker.com announces that a new market research report available catalogue: The Future of Molecular Diagnostics: Innovative technologies driving market opportunities personalized medicine http://www.reportlinker.com/p0233955/The-Future-of-Molecular-Diagnostics-Innovative-technologies-driving-market-opportunities-in-personalized ..

Lilly to Acquire Alnara Pharmaceuticals bi13751143 INDIANAPOLIS and CAMBRIDGE, Mass., July 2 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) and Alnara Pharmaceuticals, Inc. today announced they have signed a definitive merger agreement whereby Lilly acquire Alnara, a privately held biotechnology company developing protein therapeutics for the of metabolic diseases. Alnara's lead product development liprotamase ..

Connecticut looking at WellPoint breach bi13751143 New York Connecticut Attorney General Richard Blumenthal said he investigating "a massive security breach" at WellPoint that may have compromised financial and health information on almost 500,000 people

New Inspire CEO shakes up leadership bi13751143 Inspire Pharmaceuticals' new CEO, Adrian Adams, putting stamp on the company's top management team

St Vincent's CF unit stalls over builder bi13751143 PLANS FOR a specialist cystic fibrosis unit face the possibility of further delays after the hospital involved moved yesterday to recruit a new builder for the 20 million-plus project

Lilly To Acquire Alnara Pharmaceuticals bi13751143 Eli Lilly and Company (NYSE: LLY) and Alnara Pharmaceuticals, Inc. today announced they have signed a definitive merger agreement whereby Lilly acquire Alnara, a privately held biotechnology company developing protein therapeutics for the of metabolic diseases

Brake Pad Change - Home